Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twelve brokerages that are currently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $44.75.
ACHC has been the subject of a number of analyst reports. KeyCorp dropped their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Barclays cut their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. UBS Group cut their price objective on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Finally, Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd.
Get Our Latest Stock Analysis on ACHC
Acadia Healthcare Price Performance
Shares of NASDAQ:ACHC traded up $1.08 on Friday, hitting $20.15. The company's stock had a trading volume of 2,077,271 shares, compared to its average volume of 2,195,521. The company has a 50-day simple moving average of $22.13 and a 200 day simple moving average of $27.47. Acadia Healthcare has a 1 year low of $17.13 and a 1 year high of $82.40. The company has a market capitalization of $1.86 billion, a PE ratio of 13.35, a PEG ratio of 3.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. Acadia Healthcare's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $0.91 EPS. Sell-side analysts forecast that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. GAMMA Investing LLC increased its position in Acadia Healthcare by 143.8% during the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after acquiring an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. purchased a new stake in Acadia Healthcare during the first quarter valued at $222,000. Sterling Capital Management LLC increased its position in Acadia Healthcare by 59.1% during the fourth quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock valued at $216,000 after acquiring an additional 2,026 shares during the last quarter. Raiffeisen Bank International AG increased its position in Acadia Healthcare by 33.3% during the first quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock valued at $4,819,000 after acquiring an additional 40,000 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in Acadia Healthcare during the first quarter valued at $412,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.